Peptide Freeze-Drying Demand Rises as Optima Pharma Doubles Lyophilisation Capacity
Optima Pharma has doubled its Gladenbach production area as demand for freeze-drying of sensitive biologics and peptides rises, with roughly half of biologics lyophilised.